Prednisone Terminated Phase 3 Trials for Ocular Myasthenia Gravis Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00995722Efficacy of Prednisone In the Treatment of Ocular Myasthenia